Neurocrine Biosciences, Inc. (NBIX)
124.12
+1.02
(+0.83%)
USD |
NASDAQ |
Feb 13, 16:00
125.00
+0.88
(+0.71%)
After-Hours: 20:00
Neurocrine Biosciences Market Cap : 12.46B for Feb. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| STAAR Surgical Co. | 794.79M |
| Marker Therapeutics, Inc. | 23.84M |
| BioLife Solutions, Inc. | 1.070B |
| CapsoVision, Inc. | 226.25M |
| Pfizer Inc. | 156.81B |
Market Cap Related Metrics
| PE Ratio | 26.59 |
| PS Ratio | 4.444 |
| PEG Ratio | 0.6357 |
| Price to Book Value | 3.829 |
| Price to Free Cash Flow | 16.98 |
| Price | 124.12 |
| Earnings Yield | 3.76% |
| PEGY Ratio | 0.6357 |
| Operating PE Ratio | 19.97 |
| Normalized PE Ratio | 25.79 |